G. Steven Burrill
An introduction to Burrill Venture Capital
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech takes a beating in market meltdown October 01, 2008 | Press Release
Biotech outperforms market in May June 02, 2008 | Press Release
Biotech Treads Water in April May 01, 2008 | Press Release
See all NewsVenture Capital
NanoVasc, Inc. is a medical device company that provides technologies that aid patients suffering from vascular diseases. The company's initial application focuses on the debilitating peripheral arterial disease market.
